Morgan Stanley began coverage on shares of ResMed (NYSE:RMD – Free Report) in a research note issued to investors on Wednesday, MarketBeat reports. The firm issued an overweight rating and a $280.00 ...

dividend amounts are not always predictable and tend to follow the ups and downs of profitability at each company. In the case of ResMed Inc., looking at the dividend history chart for RMD below ...

Resmed (NYSE: RMD) announced today that it began a comprehensive brand evolution to unify its brand portfolio.

Morgan Stanley initiated coverage of ResMed (RMD) with an Overweight rating and A$313 price target The company has a market-leading position ...

Acquisitions are also a key part of ResMed’s ongoing success. Image Source: Zacks Investment Research The rally in the share price can be linked to the strong demand for the company’s market ...

ResMed has launched a rebrand to unify its portfolio and reflect its increasing direct-to-consumer engagement.

Despite good sleep being essential for our overall health, productivity, and relationships, millions worldwide struggle with ...

Shares of ResMed Inc. RMD shed 2.00% to $220.25 Tuesday, on what proved to be an all-around dismal trading session for the ...

ResMed Inc. (NYSE:RMD – Get Free Report)’s stock price traded down 4.3% during mid-day trading on Wednesday after an insider sold shares in the company.The stock traded as low as $221.34 and ...

https://www.tipranks.com/news/the-fly/resmed-initiated-with-an-overweight-at-morgan-stanley-2 Morgan Stanley analyst David Bailey initiated coverage of ResMed (RMD ...

Shares of ResMed Inc. RMD slipped 2.47% to $220.22 Wednesday, on what proved to be an all-around mixed trading session for ...

Sleep technology company Resmed has launched a new global campaign, enlisting the help of a ‘sleep monster’ developed by ...